Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Anaplastic Astrocytoma
- Anaplastic Meningioma
- Glial Tumor
- Medulloblastoma
- Oligodendroglioma
- Anaplastic Oligodendroglioma
- Anaplastic Pleomorphic Xanthoastrocytoma
- Neuroectodermal Tumors, Primitive
- Glioblastoma
- Atypical Meningioma
- Central Nervous System Neoplasms
- Choroid Plexus Neoplasms
- Diffuse Astrocytoma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Pleomorphic Xanthoastrocytoma
- Ependymoma
- Neuroectodermal Tumors
- Pilocytic Astrocytoma
- Teratoid Rhabdoid Tumor
- Ependymoma, Anaplastic
- Gliomatosis Cerebri
- Gliosarcoma, Adult
- Pineal Tumor
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04541082
- Collaborators
- National Institutes of Health (NIH)
- Investigators
- Principal Investigator: Mark Gilbert, MD National Institutes of Health (NIH)
Get Well Soon